RE: It's not in parallel22 Nov 2023 15:49
Can’t listen to Paul Hill ever again.
But AS did say they’d run in parallel. But the nuance is the FDA sign off. He doesn’t control this. So, parallel is an aspiration.
Facts are we know the 2 week study has not yet started. And know C7 hasn’t yet finished. We must wait on both.
AS is an awful stakeholder manager. Another reason why a trip to NASDAQ would be at odds with his communication MO. Very wooly, lacks detail, very secretive.
All data and trial updates land when they land. Over the next 2.5 weeks.